HOME >> BIOLOGY >> NEWS
UCSF begins distributing the first of its two embryonic stem cell lines

cell biology research," says Regis B. Kelly, PhD, UCSF executive vice chancellor, office of research. "The best way to determine the therapeutic potential of embryonic stem cells is to foster research efforts in many laboratories, and the role of University labs in this effort is critical, as there is less need to focus on financial implications."

"We are very pleased to be able to share these cells with other academic researchers. The effort that has gone in to getting these cells ready for distribution has been worthwhile. Studying the basic biology of embryonic stem cells is a key step in exploring their therapeutic potential," says Meri Firpo, PhD, UCSF assistant research geneticist in the Department of Obstetrics, Gynecology and Reproductive Sciences.

Firpo led the team that derived the two cell lines in the UCSF laboratory of Roger Pedersen, PhD, at that time UCSF professor and research director, reproductive genetics unit, Department of Obstetrics, Gynecology and Reproductive Sciences, and now at the University of Cambridge, in England.

Firpo and her colleagues derived the two lines of embryonic stem cells in the winter and spring of 2001. The cells were obtained from three to five day old embryos that had been left over following fertility treatments and had been donated for research. The cells were then developed into cell "lines," large quantities of genetically identical cells created by replication initiated with a single cell in the laboratory dish.

Last fall and winter, following the establishment of the NIH Human Embryonic Stem Cell Registry, the University of California Office of the President and UCSF negotiated mutually agreeable terms with several institutions for sharing the cells with academic researchers. The negotiations took place with Geron, which funded the research and holds the exclusive commercial license to the two stem cell lines; WiCell Research Institute, a nonprofit subsidiary of Wisconsin Alumni Res
'"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Sep-2002


Page: 1 2 3 4 5

Related biology news :

1. New hydrothermal vents discovered as South Pacific Odyssey research begins
2. DCI donor services begins distribution of tissue implants
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. Work begins on powering a sustainable future for the UK
5. As autumn approaches, this chickadees brain begins to expand
6. New study begins to unravel fate of toxic pollutants harbored in Arctic waters
7. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
8. Nabi Biopharmaceuticals begins human testing of novel vaccine to fight nicotine addiction
9. The pathway to anxiety begins early in life
10. DOE begins international effort to sequence tree genome
11. Montana State University begins major trout and salmonid book collection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSF begins distributing the first its two embryonic stem cell lines

(Date:4/15/2014)... 1,000 mother-child pairs, researchers from the Bloomberg School ... selective serotonin reuptake inhibitors (SSRIs), a frequently prescribed ... associated with autism spectrum disorder (ASD) and developmental ... the online edition of Pediatrics , analyzed ... cases, and population-based controls, where a uniform protocol ...
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... form could help reduce side effects by targeting the ... have developed nanoparticles that deliver one or two chemotherapy ... particles that can carry any more than that in ... a new way to build such nanoparticles, making it ... In a paper published in the Journal of ...
Breaking Biology News(10 mins):Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
Cached News: